In Kingdom Under Glass, author Jay Kirk tells the life story of Carl Akeley, the pioneering taxidermist and adventurer who once killed a leopard with his bare hands. Taxidermist David Schwendeman runs his family's 90-year-old studio and describes the techniques and hazards of modern taxidermy.
The shadow of the Earth will pass over the moon late Monday, Dec. 20, into Tuesday morning. Meteorologist and sky watcher Joe Rao discusses the lunar eclipse, and other astronomical events to look out for this winter, including an early dawn visit by Venus on Christmas Day.
Doctors at University of Iowa have been studying a female patient they call "SM" for more than 20 years. SM has a damaged amygdala, a part of the brain. As a result, she doesn't experience fear. Daniel Tranel explains what doctors have learned from SM and how that information might be useful.
Homeowners hoping to save on utility bills may want to ask Santa for a storm door or insulation. Dec. 31 is the deadline for the energy tax credits that could cut your tax bill by up to $1,500. Science Friday runs down how to save some green this winter.
Although comets were sighted at least as early as 1000 B.C., Greek natural philosophers named them sometime around 500 B.C., using the Greek word kometes for "a head with long hair." Science historian Howard Markel discusses the word's origins and the study of comets through the centuries.
Many top websites deposit tracking tools on Internet surfers' computers, in order to help online marketers target ads. Ira Flatow and guests discuss Internet tracking, and the Federal Trade Commission's suggestion that browser makers build in a sort of "do not track" button.
NeuroMetrix Inc., a Waltham-based developer of medical devices and therapies to treat neurological and spinal conditions, has appointed Nancy Katz to its board of directors.
FDA Workshop - Assuring the Safety and Effectiveness of Seizure, Cognitive Function, and TBI/Sports Concussion Diagnostic Devices, June 2-3, 2011December 17, 2010 10:33 am | by U.S. Food & Drug Administration | News | Comments
Attendees will discuss approaches and endpoints for clinical studies for these devices and how the results should be conveyed to the users so that the devices may be used effectively.
RXi Pharmaceuticals Corp. of Worcester is preparing to bring its first RNAi product into development, with the filing of an investigational new drug (IND) application for its therapeutic candidate in reducing surgical scarring.
SUNNYVALE, Calif., Dec. 17, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide...
Children's Hospital Boston scientists have initiated a three-year clinical trial to test a potential treatment for Rett Syndrome, known to cause autism in girls.
Injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent nausea and vomiting associated with cancer chemotherapy in pediatric and adult patients.
NEW YORK, Dec. 17, 2010 /- Say so-long to the days of black and white 2-D X-rays and images. From CT, to MRI and PET, medical imaging is faster, more detailed, and three-dimensional and is revolutionizing the way medicine is practiced. Thanks to years of improved imaging, today's...
Cephalon Inc. Chairman and CEO Frank Baldino Jr. died Thursday evening, the biotechnology company said. He was 57.Chief Operating Officer J. Kevin Buchi took over Baldino's day-to-day responsibilities in August and will continue doing that, said Fritz Bittenbender, vice president for public...
An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its SafetyDecember 17, 2010 7:31 am | by Bio-Medicine.Org | News | Comments
NEW YORK, Dec. 17, 2010 /- A study published this week by ITG (NYSE: ITG ) revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. ...